Articles

In the current healthcare environment, the use of medical marijuana and Cannabidiol (CBD) has expanded rapidly, often outpacing available clinical research. For healthcare providers, this gap creates a critical need for data-driven guidance to ensure patient safety.  

At Tarzana Treatment Centers (TTC), we prioritize bridging this gap through evidence-based education, prevention strategies, and specialized treatment programs. 

Overview of the Executive Order on Medical Marijuana

A recent Executive Order (EO) addresses the gap between widespread medical marijuana use and the current state of clinical research. Indeed, the Executive Order states, “Americans deserve access to the best medical treatments and research infrastructure in the world.” 

Moreover, the EO highlights that while the FDA recognizes the potential of medical marijuana to treat specific conditions — such as chronic pain, nausea, and eating disorders — the research infrastructure has faced significant historical hurdles. 

The order focuses on: 

• Regulatory Review: Evaluating the recommendation to move medical marijuana from Schedule I to Schedule III to facilitate expanded clinical trials. 

• Safety Data: Calling for rigorous studies into dosing, long-term safety, and drug-drug interactions. 

• CBD Oversight: Addressing the prevalence of mislabeled CBD products and the lack of standardized safeguards for consumers. 

Clinical Standards and Evidence-Based Education 

TTC is committed to a clinical approach that replaces assumptions with verified data. We provide comprehensive education on medical marijuana and other substances for adolescents and adults, utilizing strategies designed to improve daily functioning and facilitate recovery. 

By participating in research conducted by the National Institute on Drug Abuse (NIDA), TTC clinical staff integrates the latest scientific findings into our recovery programs, including: 

• Medications for Addiction Treatment (MAT): Utilizing proven clinical tools to support patient outcomes. 

• Trauma-Informed Care: Addressing the underlying psychological factors of substance use. 

• Technology-Supported Therapy: Leveraging modern digital tools to increase patient engagement and accessibility. 

Protecting Youth Populations from High-Potency Cannabis 

The most critical application of medical marijuana research is protecting high-risk populations, particularly youth. Adolescent brain development is uniquely sensitive to cannabinoids. TTC utilizes federally funded models — such as the Cannabis Youth Treatment Study — to address these specific risks. 

Our youth-focused efforts include: 

• Intervention in Schools and Courts: Mitigating academic decline and self-esteem challenges linked to early-onset use. 

• Addressing THC Potency: Monitoring the clinical implications of rising THC levels and their amplified effects on adolescent mental health. 

• Functional Recovery: Helping young people regain cognitive focus and social stability. 

Focused Support for Youth and Families

Is a young person in your life struggling with the effects of marijuana use or academic decline? Evidence-based interventions are the most effective way to foster a healthy future. Our specialized youth programs offer the clinical support and education needed to navigate such complexities. 

Contact Our Youth Services Team Today and Learn More About Adolescent Recovery Programs 

Advancing Care Through Clinical Clarity

Expanding research on medical marijuana and CBD is essential for strengthening patient care and supporting informed clinical choices. At TTC, we remain committed to the principle that science must guide treatment. 

If you or a loved one has questions regarding cannabis use disorder or recovery support, contact Tarzana Treatment Centers. Clinical excellence starts with an informed conversation.